DR. JIMMY S GANDY O.D.
Prescription History 1366447310
Optometrist in Rayville, LA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. JIMMY S GANDY O.D., an active Optometrist specialist practicing in Rayville, LA. Our medical registry currently tracks 15 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 858 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 422 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other LA PrescribersVs. LA Avg |
|---|---|---|---|
| Latanoprost | 422 | $19.10 | ▲ More than typical |
About Latanoprost: Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). Show more ▾ It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness. A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA. In 2023, this provider wrote 422 Medicare prescriptions for Latanoprost, about 2.5 times the volume of the typical Louisiana prescriber of this medication (169). Medicare paid an average of $19.10 per fill, versus $17.94 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 771.3 30-Day Fills standardized to 30-day supplies 22,173 Days of Medication total across all patients in 2023 | |||
| Timolol Maleate | 91 | $15.91▼ below LA avg | ≈ Typical |
About Timolol Maleate: This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers. A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor. In 2023, this provider wrote 91 Medicare prescriptions for Timolol Maleate, about 1.2 times the volume of the typical Louisiana prescriber of this medication (77). Medicare paid an average of $15.91 per fill, versus $19.05 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 177.8 30-Day Fills standardized to 30-day supplies 5,136 Days of Medication total across all patients in 2023 | |||
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 54 | $21.57▼ below LA avg | ▼ Less than typical |
About Dorzolamide-Timolol: This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors. In 2023, this provider wrote 54 Medicare prescriptions for Dorzolamide-Timolol, about half the volume of the typical Louisiana prescriber of this medication (101). Medicare paid an average of $21.57 per fill, versus $29.01 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 95.8 30-Day Fills standardized to 30-day supplies 2,870 Days of Medication total across all patients in 2023 | |||
| Prednisolone Acetate | 36 | $53.37 | ▼ Less than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. In 2023, this provider wrote 36 Medicare prescriptions for Prednisolone Acetate, about a third of the volume of the typical Louisiana prescriber of this medication (118). Medicare paid an average of $53.37 per fill, versus $49.84 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 39.2 30-Day Fills standardized to 30-day supplies 846 Days of Medication total across all patients in 2023 | |||
| Travoprost | 33 | $138.01▼ below LA avg | ≈ Typical |
About Travoprost: Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 33 Medicare prescriptions for Travoprost, about the same volume as the typical Louisiana prescriber of this medication (34). Medicare paid an average of $138.01 per fill, versus $195.40 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 38.8 30-Day Fills standardized to 30-day supplies 1,090 Days of Medication total across all patients in 2023 | |||
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 32 | $64.65▼ below LA avg | ≈ Typical |
About Tobramycin-Dexamethasone: This medication is used to treat or prevent eye infections. Show more ▾ This medication contains two drugs. Tobramycin belongs to a class of drugs called aminoglycoside antibiotics. It works by stopping the growth of bacteria. Dexamethasone belongs to a class of drugs called corticosteroids. It works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness. A topical preparation of tobramycin and dexamethasone that is used for treating or preventing superficial bacterial infections of the eye. In 2023, this provider wrote 32 Medicare prescriptions for Tobramycin-Dexamethasone, about the same volume as the typical Louisiana prescriber of this medication (31). Medicare paid an average of $64.65 per fill, versus $78.18 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 32.7 30-Day Fills standardized to 30-day supplies 425 Days of Medication total across all patients in 2023 | |||
| XiidraLifitegrast | 28 | $987.71 | ≈ Typical |
About Xiidra: This medication is used to treat dry eye disease. In 2023, this provider wrote 28 Medicare prescriptions for Xiidra, about the same volume as the typical Louisiana prescriber of this medication (27). Medicare paid an average of $987.71 per fill, versus $893.33 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 38 30-Day Fills standardized to 30-day supplies 1,140 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate | 27 | $15.07▼ below LA avg | ▼ Less than typical |
About Brimonidine Tartrate: This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Show more ▾ Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details. A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 27 Medicare prescriptions for Brimonidine Tartrate, about a third of the volume of the typical Louisiana prescriber of this medication (75). Medicare paid an average of $15.07 per fill, versus $37.57 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 44.3 30-Day Fills standardized to 30-day supplies 1,283 Days of Medication total across all patients in 2023 | |||
| RestasisCyclosporine | 23 | $1,195.19 | ▼ Less than typical |
About Restasis: Cyclosporine eye drops are used to treat a certain type of dry eyes. Show more ▾ They work by increasing the amount of tears you make. A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. In 2023, this provider wrote 23 Medicare prescriptions for Restasis, about half the volume of the typical Louisiana prescriber of this medication (48). Medicare paid an average of $1,195.19 per fill, versus $1,001.30 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 43 30-Day Fills standardized to 30-day supplies 1,245 Days of Medication total across all patients in 2023 | |||
| Fluorometholone | 22 | $64.75▼ below LA avg | ▼ Less than typical |
About Fluorometholone: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Fluorometholone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. A glucocorticoid employed, usually as eye drops, in the treatment of allergic and inflammatory conditions of the eye. It has also been used topically in the treatment of various skin disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p732) In 2023, this provider wrote 22 Medicare prescriptions for Fluorometholone, about half the volume of the typical Louisiana prescriber of this medication (39). Medicare paid an average of $64.75 per fill, versus $77.10 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 23.2 30-Day Fills standardized to 30-day supplies 493 Days of Medication total across all patients in 2023 | |||
| Loteprednol Etabonate | 22 | $204.49 | ≈ Typical |
About Loteprednol Etabonate: This medication is used to temporarily relieve seasonal allergy symptoms of the eyes such as swelling, redness, and itching. Show more ▾ Loteprednol belongs to a class of drugs known as corticosteroids. An androstadiene derivative corticosteroid that is used as an ANTI-ALLERGIC AGENT for the treatment of inflammatory and allergic eye conditions. In 2023, this provider wrote 22 Medicare prescriptions for Loteprednol Etabonate, about 79% of the volume of the typical Louisiana prescriber of this medication (28). Medicare paid an average of $204.49 per fill, versus $197.37 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25.5 30-Day Fills standardized to 30-day supplies 625 Days of Medication total across all patients in 2023 | |||
| CombiganBrimonidine Tartrate/Timolol | 20 | $345.55▼ below LA avg | ▼ Less than typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 20 Medicare prescriptions for Combigan, about half the volume of the typical Louisiana prescriber of this medication (47). Medicare paid an average of $345.55 per fill, versus $351.06 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 25.4 30-Day Fills standardized to 30-day supplies 701 Days of Medication total across all patients in 2023 | |||
| LumiganBimatoprost | 18 | $324.64▼ below LA avg | ▼ Less than typical |
About Lumigan: Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure. A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION. In 2023, this provider wrote 18 Medicare prescriptions for Lumigan, about a third of the volume of the typical Louisiana prescriber of this medication (63). Medicare paid an average of $324.64 per fill, versus $400.28 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 20.1 30-Day Fills standardized to 30-day supplies 569 Days of Medication total across all patients in 2023 | |||
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 17 | $260.59 | ▼ Less than typical |
About Brimonidine Tartrate-Timolol: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2023, this provider wrote 17 Medicare prescriptions for Brimonidine Tartrate-Timolol, about 71% of the volume of the typical Louisiana prescriber of this medication (24). Medicare paid an average of $260.59 per fill, versus $255.34 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 27.8 30-Day Fills standardized to 30-day supplies 820 Days of Medication total across all patients in 2023 | |||
| RocklatanNetarsudil Mesylat/Latanoprost | 13 | $600.59 | ▼ Less than typical |
About Rocklatan: Netarsudil/latanoprost is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). Show more ▾ Lowering high pressure inside the eye can help prevent vision loss or blindness. In 2023, this provider wrote 13 Medicare prescriptions for Rocklatan, about a third of the volume of the typical Louisiana prescriber of this medication (45). Medicare paid an average of $600.59 per fill, versus $461.02 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 20.4 30-Day Fills standardized to 30-day supplies 570 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. JIMMY S GANDY O.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Optometrist prescribing approach at this Rayville, LA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among LA prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
